108 related articles for article (PubMed ID: 23328514)
21. [PTHrP and bone sialoprotein as prognostic markers for developing bone metastases in breast cancer patients].
Loibl S; Königs A; Kaufmann M; Costa SD; Bischoff J
Zentralbl Gynakol; 2006 Dec; 128(6):330-5. PubMed ID: 17213971
[TBL] [Abstract][Full Text] [Related]
22. Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors.
Kelly PJ; Lin NU; Claus EB; Quant EC; Weiss SE; Alexander BM
Cancer; 2012 Apr; 118(8):2014-20. PubMed ID: 21918959
[TBL] [Abstract][Full Text] [Related]
23. Response to second-line chemotherapy in patients with metastatic breast carcinoma previously responsive to first-line treatment: prognostic factors.
Brun B; Benchalal M; Lebas C; Piedbois P; Lin M; Lebourgeois JP
Cancer; 1997 Jun; 79(11):2137-46. PubMed ID: 9179060
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors for patients with liver metastases from breast cancer.
Eichbaum MH; Kaltwasser M; Bruckner T; de Rossi TM; Schneeweiss A; Sohn C
Breast Cancer Res Treat; 2006 Mar; 96(1):53-62. PubMed ID: 16319993
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer.
Leissner P; Verjat T; Bachelot T; Paye M; Krause A; Puisieux A; Mougin B
BMC Cancer; 2006 Aug; 6():216. PubMed ID: 16945123
[TBL] [Abstract][Full Text] [Related]
26. [Characteristics and prognostic factors of postoperative chemotherapy for female breast cancer patients under 30 years of age: a report of 129 patients].
Wang ZH; Xu BH
Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):111-3. PubMed ID: 15946553
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors for recurrent breast cancer patients with an isolated, limited number of lung metastases and implications for pulmonary metastasectomy.
Yhim HY; Han SW; Oh DY; Han W; Im SA; Kim TY; Kim YT; Noh DY; Chie EK; Ha SW; Park IA; Bang YJ
Cancer; 2010 Jun; 116(12):2890-901. PubMed ID: 20564396
[TBL] [Abstract][Full Text] [Related]
28. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
Zhang HM; Zhang BN; Xuan LX; Zhao P
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
[TBL] [Abstract][Full Text] [Related]
29. Incidence and prognostic factors of Japanese breast cancer patients with bone metastasis.
Oka H; Kondoh T; Seichi A; Hozumi T; Nakamura K
J Orthop Sci; 2006 Jan; 11(1):13-9. PubMed ID: 16437343
[TBL] [Abstract][Full Text] [Related]
30. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
[TBL] [Abstract][Full Text] [Related]
31. Survival and breast relapse in 3834 patients with T1-T2 breast cancer after conserving surgery and adjuvant treatment.
Livi L; Paiar F; Saieva C; Scoccianti S; Dicosmo D; Borghesi S; Agresti B; Nosi F; Orzalesi L; Santini R; Barca R; Biti GP
Radiother Oncol; 2007 Mar; 82(3):287-93. PubMed ID: 17188382
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors in 1,521 melanoma patients with distant metastases.
Barth A; Wanek LA; Morton DL
J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
[TBL] [Abstract][Full Text] [Related]
33. Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases.
Veronesi A; de Giacomi C; Magri MD; Lombardi D; Zanetti M; Scuderi C; Dolcetti R; Viel A; Crivellari D; Bidoli E; Boiocchi M
BMC Cancer; 2005 Jul; 5():70. PubMed ID: 15996267
[TBL] [Abstract][Full Text] [Related]
34. Survival and prognostic factors of stage I-III breast cancer.
Laohavinij S; Ruikchuchit K; Maneechavakajorn J
J Med Assoc Thai; 2013 Mar; 96 Suppl 3():S23-34. PubMed ID: 23682519
[TBL] [Abstract][Full Text] [Related]
35. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
[TBL] [Abstract][Full Text] [Related]
36. Real-world outcomes of different treatments in the management of patients with HER-2 positive breast cancer: a retrospective study.
Chitapanarux I; Trakultivakorn H; Srisukho S; Somwangprasert A; Watcharachan K; Srikawin J; Chaiwun B; Traisathit P
J Med Assoc Thai; 2013 Jun; 96(6):709-15. PubMed ID: 23951829
[TBL] [Abstract][Full Text] [Related]
37. Uncertain benefit from surgery in patients with lung metastases from breast carcinoma.
Planchard D; Soria JC; Michiels S; Grunenwald D; Validire P; Caliandro R; Girard P; Le Chevalier T
Cancer; 2004 Jan; 100(1):28-35. PubMed ID: 14692021
[TBL] [Abstract][Full Text] [Related]
38. Endocrine therapy in obese patients with primary breast cancer: another piece of evidence in an unfinished puzzle.
Wolters R; Schwentner L; Regierer A; Wischnewsky M; Kreienberg R; Wöckel A
Breast Cancer Res Treat; 2012 Feb; 131(3):925-31. PubMed ID: 22080246
[TBL] [Abstract][Full Text] [Related]
39. Treatment outcome and prognostic factors for patients with bone-only metastases of breast cancer: a single-institution retrospective analysis.
Niikura N; Liu J; Hayashi N; Palla SL; Tokuda Y; Hortobagyi GN; Ueno NT; Theriault RL
Oncologist; 2011; 16(2):155-64. PubMed ID: 21266401
[TBL] [Abstract][Full Text] [Related]
40. Thirty-Year Trends of Survival and Time-Varying Effects of Prognostic Factors in Patients With Metastatic Breast Cancer-A Single Institution Experience.
Rogoz B; Houzé de l'Aulnoit A; Duhamel A; Houzé de l'Aulnoit D
Clin Breast Cancer; 2018 Jun; 18(3):246-253. PubMed ID: 28988656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
